KaydedilenlerDerginizi ekleyin

Dergiler / Experimed / 2026 / Volume: 16 Issue: 1

Unveiling a Genetic Link Between Adenomyosis and Carcinogenesis via Whole-Exome Sequencing: Could NTN1-Mediated Epithelial Mesenchymal Transition Be a Shared Mechanism?

Sevcan Aydın(İstanbul University, Graduate School of Health Sciences, Department of Genetics)0009-0009-7765-6124
Nura Fitnat Topbaş Selçuki(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL ŞİŞLİ HAMİDİYE ETFAL HEALTH RESEARCH CENTER, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY)0000-0002-5749-9987
Pinar Yalcin Bahat(University of Health Sciences, İstanbul Kanuni Sultan Süleyman Training and Research Hospital, Department of Obstetrics and Gynecology,)0000-0003-2558-1924
Feyza Nur Tuncer(ISTANBUL UNIVERSITY, AZIZ SANCAR INSTITUTE OF EXPERIMENTAL MEDICINE, DEPARTMENT OF GENETICS)0000-0001-8233-1839
Sayfa
—
Yayın Tarihi
2026-08-27
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Functional studies are required to further investigate the impact of this novel variant.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Adenomyosis is a benign uterine condition characterized by the invasion of endometrial glands and stromal tissue into the myometrium.
📊
Temel Bulgular & Veri:A novel genetic variant, NTN1 p. (Ser271Ala), which triggers EMT and encourages tumor growth, was identified across all cases.
💡
Sonuç & Katkı:Functional studies are required to further investigate the impact of this novel variant.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Adenomyosis · Cancer · Epithelial-Mesenchymal Transition

Abstract

Objective: Adenomyosis is a benign uterine condition characterized by the invasion of endometrial glands and stromal tissue into the myometrium. It exhibits cancer-like characteristics, such as epithelial-mesenchymal transition (EMT). We aimed to identify shared genetic variants between different cancers and adenomyosis, focusing on a family with women affected by both conditions. Materials and Methods: Among the four women with a family history of adenomyosis and carcinogenesis, two received pathologically confirmed diagnosis of ovarian adenocarcinoma and clear cell renal cell carcinoma (ccRCC). Genomic material was obtained from blood leukocytes, followed by whole exome sequencing to investigate novel and rare genetic variants related to both conditions. Results: Pathological evaluations excluded adenomyosis in the case diagnosed with ovarian mucinous adenocarcinoma, whereas it was confirmed in the case with ccRCC. A novel genetic variant, NTN1 p. (Ser271Ala), which triggers EMT and encourages tumor growth, was identified across all cases. The DynaMut prediction tool reported that this variant has a destabilizing impact on protein structure, which gained further support from four distinct prediction tools (ENCoM, mCSM, DUET, and MUpro). Additional rare variants in five genes were shared among the cases diagnosed with cancer. Conclusion: NTN1 may be involved in the pathobiology of carcinogenesis and adenomyosis, potentially linking these conditions through EMT. Functional studies are required to further investigate the impact of this novel variant.

🔖

Bu Makaleye Atıf Yap

Aydın, S., Selçuki, N. F. T., Bahat, P. Y., Tuncer, F. N. (2026). Unveiling a Genetic Link Between Adenomyosis and Carcinogenesis via Whole-Exome Sequencing: Could NTN1-Mediated Epithelial Mesenchymal Transition Be a Shared Mechanism?. Experimed, Volume: 16 Issue: 1. https://doi.org/10.26650/experimed.1877834

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (29)

  1. Donnez J, Stratopoulou CA, Dolmans MM. Uterine Adenomyosis: From disease pathogenesis to a new medical approach using gnrh antagonists. Int J Environ Res Public Health 2021; 18(19): 9941. google scholar
  2. Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Steril 2018; 109(3): 380-8. google scholar
  3. Zhai J, Vannuccini S, Petraglia F, Giudice LC. Adenomyosis: mechanisms and pathogenesis. Semin Reprod Med 2020; 38(2-03): 129-43. google scholar
  4. Egashira H, Ishida H, Takashima A. Adenocarcinoma arising in adenomyosis: a narrative review of disease concept, molecular pathogenesis, and clinical challenges. Cureus 2026; 18: e104162. google scholar
  5. Baba A, Yamazoe S, Dogru M, Ogawa M, Takamatsu K, Miyauchi J. Clear cell adenocarcinoma arising from adenomyotic cyst: A case report and literature review. J Obstet Gynaecol Res 2016; 42(2): 217–23. google scholar
  6. Provendier A, Angeles MA, Meyrignac O, Illac C, Ducassou A, Martínez-Gómez C, et al. Clear cell adenocarcinoma arising from the abdominal wall after cesarean section in a patient with uterine adenomyosis. J Surg Case Rep 2020; 2020(4): rjaa070. google scholar
  7. Caramelo O, Marinho C, Rebelo T, Amaral N, Mota F, Xavier da Cunha F, et al. A case of endometrial stromal sarcoma with synchronous bilateral adenocarcinoma of ovary. Case Rep Obstet Gynecol 2012; 2012: 687510. google scholar
  8. Machida H, Maeda M, Cahoon SS, Scannell CA, Garcia-Sayre J, Roman LD, et al. Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: are these two different entities? Arch Gynecol Obstet 2017; 295(6): 1459-68. google scholar
  9. Bilyk O, Coatham M, Jewer M, Postovit LM. Epithelial-to-mesenchymal transition in the female reproductive tract: from normal functioning to disease pathology. Front Oncol 2017; 7: 145. google scholar
  10. Wang LN, Ren L, Li L, Liu SL, Lu HJ, Guo ML, et al. Role of SMOC2 in adenomyosis: implications for ECM remodeling and EMT pathogenesis. BMC Womens Health 2025; 25(1): 155. google scholar
  11. Bulun SE, Yildiz S, Adli M, Wei JJ. Adenomyosis pathogenesis: insights from next generation sequencing. Hum Reprod Update 2021; 27(6): 1086-97. google scholar
  12. Kina BG, Topbas Selcuki NF, Bahat PY, Usta T, Aydin S, Rahmioglu N, et al. Whole exome sequencing reveals novel candidate variants for endometriosis utilizing multiple affected members in a single family. Mol Genet Genomic Med 2024; 12(1): e2312. google scholar
  13. Harmsen MJ, Van den Bosch T, de Leeuw RA, Dueholm M, Exacoustos C, Valentin L, et al. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure. Ultrasound Obstet Gynecol 2022; 60(1): 118-31. google scholar
  14. Lin T, Allaire C, As-Sanie S, Stratton P, Vincent K, Adamson GD, et al. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: V. Physical examination standards in endometriosis research. Fertil Steril 2024; 122(2): 304-15. google scholar
  15. Tuncer FN, Eser Ma N, Aydin S, Topbas Selcuki NF, Yildiz Ozaydin I, Oral E. Exome-based identification of candidate genes in sporadic adenomyosis cases. Diagnostics (Basel) 2025; 15(23): 3069. google scholar
  16. Torun D, Arslan M, Yüksel Z. Coexistence of severe developmental delay, epilepsy, and hemangioma in Snijders Blok-Fisher syndrome suggests the presence of a POU3F3related SNIBFIS endophenotype: a case report. Am J Med Genet A 2021; 185(5): 1554-60. google scholar
  17. Rodrigues CH, Pires DE, Ascher DB. DynaMut: predicting the impact of mutations on protein conformation, flexibility, and stability. Nucleic Acids Res 2018; 46(W1): W350-55. google scholar
  18. Moreno-Manuel A, Jantus-Lewintre E, Simões I, Aranda F, Calabuig-Fariñas S, Carreras E, et al. CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer. Transl Lung Cancer Res 2020; 9(4): 1074-83 google scholar
  19. Huang M, Ding J, Wu X, Peng X, Wu G, Peng C, et al. EZH2 affects malignant progression and DNA damage repair of lung adenocarcinoma cells by regulating RAI2 expression. Mutat Res 2022; 825: 111792. google scholar
  20. Lou X, Deng W, Shuai L, Chen Y, Xu M, Xu J, et al. RAI2 acts as a tumor suppressor with functional significance in gastric cancer. Aging (Albany NY) 2023; 15(21): 11831-44. google scholar
  21. Xu D, Zhang S, Zhang S, Liu H, Li P, Yu L, et al. NOD2 may be a biomarker for the survival of kidney cancer patients. Oncotarget 2017; 8(60): 101489-99. google scholar
  22. Magnowski P, Medrek K, Magnowska M, Stawicka M, Kedzia H, Górski B, et al. The 3020insC NOD2 gene mutation in patients with ovarian cancer. Ginekol Pol 2008; 79(8): 544-9. google scholar
  23. Gustafsson A, Boström AK, Ljungberg B, Axelson H, Dahlbäck B. Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma. PLoS One 2009; 4(10): e7575. google scholar
  24. Hwang J, Kim H, Han J, Lee J, Hong S, Kim S, et al. Identification of survival-specific genes in clear cell renal cell carcinoma using a customized next-generation sequencing gene panel. J Pers Med 2022; 12(1): 113. google scholar
  25. Papanastasiou AD, Pampalakis G, Katsaros D, Sotiropoulou G. Netrin-1 overexpression is predictive of ovarian malignancies. Oncotarget 2011; 2(5): 363-7. google scholar
  26. Li Y, Xiao M, Guo F. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis. Tumour Biol 2017; 39(5): 1010428317705508. google scholar
  27. Cassier PA, Navaridas R, Bellina M, Rama N, Ducarouge B, Hernandez-Vargas H, et al. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer. Nature 2023; 620(7973): 409-16. google scholar
  28. Dun XP, Parkinson DB. Role of Netrin-1 signaling in nerve regeneration. Int J Mol Sci 2017; 18(3): 491. google scholar
  29. Kefeli U, Ucuncu Kefeli A, Cabuk D, Isik U, Sonkaya A, Acikgoz O, et al. Netrin-1 in cancer: potential biomarker and therapeutic target. Tumour Biol 2017; 39(4): 1010428317698388. google scholar